Bangladesh’s recent measles outbreak, which has claimed hundreds of lives, is more than a public health failure.
This outbreak reflects a deeper pattern of policy manipulation, weak governance, and a dangerous drift toward a deals-based system where urgency is lost in bureaucracy.
What should have been a routine immunization effort turned into a tragedy due to delayed vaccine procurement and institutional inertia.
When critical information fails to reach decision-makers in time, it signals not just inefficiency but elements of state capture, where systems serve processes rather than people.
A health system built by millions cannot be allowed to be weakened by a few layers of inaction.
Yet measles is only a warning. Bangladesh’s healthcare infrastructure has historically shown signs of structural fragility -- limited isolation units, inadequate pediatric ICU capacity, and insufficient outbreak training.
These gaps expose a broader cycle of neglect and decay where reforms are discussed but not executed.
The consequences are visible in overcrowded hospitals, overwhelmed doctors, and families forced into desperate searches for care.
“Growth without justice collapses” applies not only to economics but also to healthcare access, where inequality in preparedness translates directly into loss of life.
Now, the country faces a more predictable but equally dangerous threat: Dengue.
Once an urban seasonal disease, it has evolved into a nationwide crisis, spreading into rural areas and affecting the most vulnerable.
Despite its recurring nature, the response remains fragmented -- marked by blame between institutions rather than coordination.
This reflects an “unholy nexus” of administrative disconnect, where responsibilities are diffused and accountability diluted.
Without a unified roadmap, mosquito control efforts remain inconsistent, allowing the disease to thrive.
A critical yet under-discussed dimension of dengue preparedness is the supply of intravenous (IV) fluids -- the backbone of treatment.
Bangladesh’s pharmaceutical sector has the capacity to meet national demand, yet it is constrained by outdated pricing structures and delayed policy decisions.
This creates a paradox where local capability exists but is undermined by regulatory stagnation.
Last year’s reliance on costly imports exposed the risks of ignoring domestic industry -- a classic feature of a crony-leaning system, where inefficiencies force dependence on external solutions.
Rising global costs, influenced by geopolitical tensions involving Iran, have further intensified the pressure on local producers.
This is where the health crisis intersects with economic governance. A system that delays critical decisions, ignores industry signals, and reacts only under pressure risks falling into a broader cycle of plunder and decay -- not through intent, but through inaction.
When essential supplies become uncertain during a predictable outbreak, it reflects not scarcity, but misalignment of priorities. “Built by millions, captured by a few decisions” may well define the current trajectory if corrective measures are not taken.
Bangladesh today stands at a crossroads. It can either strengthen its institutions, invest in preparedness, and build a people-centred health system -- or continue along a path where fragmented authority and delayed action erode resilience.
The lessons from measles must translate into immediate reforms: Stronger surveillance, faster procurement, coordinated dengue control, and policy support for essential medical production.
The next crisis is not a question of if, but when. And if the current patterns persist, the outcome will be painfully familiar -- another preventable tragedy in a system that knew the risks but failed to act.
MD Saiful Islam is Executive Director, Bangladesh Association of Pharmaceutical Industries and a former Additional Secretary.
